Latest / The Demographics Podcast with Fexingo: Aging Populations, Birth Rates, and Economic Impact
How Falling Birth Rates Are Reshaping the Pharmaceutical Industry
In this episode, Lucas and Luna dive into the demographic shift quietly transforming the pharmaceutical industry. With birth rates declining across the developed world, drug companies are pivoting from pediatric to geriatric R&D. Lucas cites IQVIA data showing a 15% drop in U.S. pediatric prescriptions over the past decade. They explore how Pfizer, Novartis, and smaller biotechs are reallocating resources toward chronic conditions of aging—like Alzheimer's, osteoarthritis, and cardiovascular disease. The hosts also discuss the ripple effects on drug pricing, clinical trial recruitment…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.